相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 询价记录
- 技术资料
- 英文名:
ODN 2006 (ODN 7909)
- 供应商:
研卉生物
- 规格:
200 ug
ynonyms: ODN 7909, PF_3512676
Specificity: human TLR9 agonist
Working concentration: 5 µM (10 μg/ml)
Solubility: 5 mg/ml in water
ODN 2006 sequence
5’-tcgtcgttttgtcgttttgtcgtt-3’ (24 mer)
Note: Bases are phosphorothioate (nuclease resistant).
CpG ODNs are synthetic oligonucleotides that contain unmethylated CpG dinucleotides in particular sequence contexts (CpG motifs) [1]. These CpG motifs are present at a 20-fold greater frequency in bacterial DNA compared to mammalian DNA. CpG ODNs are recognized by Toll-like receptor 9 (TLR9) leading to strong immunostimulatory effects [2].
Three types of stimulatory CpG ODNs have been identified, types A, B and C, which differ in their immune-stimulatory activities [3-4]. Type A CpG ODNs are characterized by a phosphodiester central CpG-containing palindromic motif and a phosphorothioate 3’ poly-G string. They induce high IFN-α production from plasmacytoid dendritic cells (pDC) but are weak stimulators of TLR9-dependent NF-κB signaling. Type B CpG ODNs contain a full phosphorothioate backbone with one or more CpG dinucleotides. They strongly activate B cells but stimulate weakly IFN-α secretion. Type C CpG ODNs combine features of both types A and B. They contain a complete phosphorothioate backbone and a CpG-containing palindromic motif. Type C CpG ODNs induce strong IFN-α production from pDC and B cell stimulation.
ODN 2006 is a CpG ODN type B specific for human TLR9.
1. Krieg, A.M. et al., 1995. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature, 374(6522):546-9.
2. Bauer, S. et al., 2001. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. PNAS. 98(16):9237-42.
3. Krug A. et al., 2001. Identification of CpG oligonucleotide sequences with high induction of IFN- alpha/beta in plasmacytoid dendritic cells. Eur J Immunol, 31(7): 2154-63.
4. Marshall JD. et al., 2005. Superior activity of the type C class of ISS in vitro and in vivo across multiple species. DNA Cell Biol. 24(2):63-72.
ODN 2006 (ODN 7909) | Cat. # : tlrl-2006
TLR9 Agonist - Stimulatory CpG ODN, Class B, Human preferred
ODN 2006 control (ODN 2137) | Cat. # : tlrl-2006c-5
ODN 2137 : Negative control for ODN 2006
ODN 2006-G5 | Cat. # : tlrl-2006g5-1
TLR9 Agonist - Stimulatory CpG ODN, Class B, Human preferred
ODN 2006-G5 | Cat. # : tlrl-2006g5-5
TLR9 Agonist - Stimulatory CpG ODN, Class B, Human preferred
ODN 2006 Biotin | Cat. # : tlrl-2006b
TLR9 Agonist - Biotin-labelled CpG ODN 2006, Class B, Human preferred
ODN 2006 control (ODN 2137) | Cat. # : tlrl-2006c-1
ODN 2137 : Negative control for ODN 2006
ODN 2006 (ODN 7909) | Cat. # : tlrl-2006-5
TLR9 Agonist - Stimulatory CpG ODN, Class B, Human preferred
ODN 2006 control (ODN 2137) | Cat. # : tlrl-2006c
ODN 2137 : Negative control for ODN 2006
ODN 2006-G5 | Cat. # : tlrl-2006g5
TLR9 Agonist - Stimulatory CpG ODN, Class B, Human preferred
ODN 2006 FITC | Cat. # : tlrl-2006f
TLR9 Agonist - FITC-labelled CpG ODN 2006, Class B, Human preferred
ODN 2006 (ODN 7909) | Cat. # : tlrl-2006-1
TLR9 Agonist - Stimulatory CpG ODN, Class B, Human preferred
ODN 2006-G5 control | Cat. # : tlrl-2006g5c
Negative control for ODN 2006-G5
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
- 作者
- 内容
- 询问日期
技术资料暂无技术资料 索取技术资料







